logo-loader
Proactive Group

Bioxytran Inc in advanced talks to take its two exciting assets into the clinic

David Platt, chief executive of Bioxytran Inc (OTCMKTS:BIXT), chats to Proactive Investors at the Spring Investor Summit 2019 in New York City.

The company's mission is to develop anti-necrosis drugs that treat a variety of medical conditions resulting from Ischemia.

Its lead candidate BXT-25 is a drug that carries oxygen to tissues when the flow of blood is blocked.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: The Green Organic Dutchman delivers first order to Ontario...

The Green Organic Dutchman (TSE:TGOD-US: TGODF) Director of National Sales, Ed Corcoran joined Steve Darling from Proactive Vancouver to discuss the company delivering their first order to the Ontario Cannabis Store. Corcoran telling Proactive when their product will be available in retail...

1 day, 1 hour ago

2 min read